PENDARVIS DAVID 4
4 · RESMED INC · Filed Nov 23, 2022
Insider Transaction Report
Form 4
RESMED INCRMD
PENDARVIS DAVID
Sr. VP, General Counsel
Transactions
- Tax Payment
ResMed Common Stock
2022-11-23$224.40/sh−6,911$1,550,828→ 106,789 total - Award
ResMed Common Stock
2022-11-23+12,389→ 113,700 total
Footnotes (2)
- [F1]Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met.
- [F2]Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019.